Pharma
Guardtech Group raising the bar with new Cleanroom Solutions website
Haverhill cleanroom construction company elevate their turnkey offering with launch of ground-breaking new website ...
Breaking into Healthcare Markets
Everything medtech and healthtech innovators need to know about breaking into the NHS or key export markets. ...
New Approaches to Facilitate Drug Discovery
Join Medicilon at 2023 Annual UK Symposium: New Approaches to Facilitate Drug Discovery New approaches applied to drug discovery by the medical community and pharmaceutical industry have a direct impact on the development of improved, novel, and curative therapies for patients. Medicil...
Maxion Therapeutics awarded £2 million Innovate UK funding to develop ion channel antibodies for “hard-to-treat" autoimmune diseases
Biotechnology company Maxion Therapeutics announces it has been awarded a prestigious GBP £2 million grant from Innovate UK, as part of its Biomedical Catalyst 2022 Round 2: Industry-led R&D funding competition. ...
Cresset April 2023 Newsletter
Explore some advanced computational chemistry methods such as FEP and Python workflows, alongside a range of exciting news in the Cresset April newsletter! ...
Cambridge winners in Microbiology Society awards
Two Addenbrooke’s experts who led the fight against COVID-19 are to be presented with prestigious awards at a major national conference this week. ...
CCDC Webinar: Boosting Research Efficiency in Industry with FAIR Data
The ability to leverage existing data, whether public or proprietary, strengthens chemistry research. ...
Cambridge Innovation Capital invests in Complement Therapeutics’ €72 Million Series A Funding
Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life sciences businesses in the Cambridge ecosystem, has invested in Complement Therapeutics’ €72 Million Series A funding round led by Gimv and co-led by Forbion, alongside existing investor B...
How COVID-19 could revolutionize the UK pharmaceutical procurement landscape: a DOAC procurement case study
Direct oral anticoagulants (DOACs) are widely used pharmaceutical products which represent a significant cost to the healthcare system. In 2021, National Health Service England (NHSE) spent around £690 million ($840 million) on DOACs in primary care1. ...
Charles River Associates announces six VP promotions
Charles River Associates announces the promotions of six new vice presidents. Sean Sheridan in CRA’s Intellectual Property Practice, Eddie Li, Erika Sloan, and Griff Vinton in CRA’s Life Sciences Practice, a ...